RSLDX | TGSAX | RSLDX / TGSAX | |
Total Expense Ratio | 0.80 | 1.06 | 75% |
Annual Report Gross Expense Ratio | 0.80 | 1.06 | 75% |
Fund Existence | 10 years | 29 years | - |
Gain YTD | 11.873 | 7.453 | 159% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 100000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 81.4B | 831M | 9,795% |
Annual Yield % from dividends | 0.79 | 1.28 | 61% |
Returns for 1 year | 12.59 | 2.57 | 491% |
Returns for 3 years | 37.55 | 30.12 | 125% |
Returns for 5 years | 19.17 | 14.74 | 130% |
Returns for 10 years | N/A | 29.81 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 47.85 | 0.57 | +1.21% |
SPDR® S&P Pharmaceuticals ETF | |||
MYI | 10.69 | 0.12 | +1.14% |
Blackrock Muniyield Quality Fund III | |||
REKT | 18.74 | 0.20 | +1.07% |
Direxion Daily Crypto Industry Bear1XETF | |||
IDEV | 78.70 | 0.36 | +0.46% |
iShares Core MSCI Intl Dev Mkts ETF | |||
ENOR | 27.98 | 0.01 | +0.04% |
iShares MSCI Norway ETF |